Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on August 28, 2007
JNCI Journal of the National Cancer Institute 2007 99(17):1345-1346; doi:10.1093/jnci/djm092
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/17/1345    most recent
djm092v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Fazio, N.
Right arrow Articles by Goldhirsch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fazio, N.
Right arrow Articles by Goldhirsch, A.
Related Collections
Right arrowArticle about this Correspondence
Right arrowRelated Article in JNCI
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

Nicola Fazio, Roberto Biffi, Giuseppe Curigliano, Katia Lorizzo, Maria Giulia Zampino, Filippo de Braud, Antonio Chiappa, Arnaud Roth, Aron Goldhirsch

Affiliations of authors: European Institute of Oncology, Milan, Italy (NF, RB, GC, KL, MGZ, FDB, AC, AG); Geneva University Hospital, Geneva, Switzerland (AR)

Correspondence to: Nicola Fazio, MD, Department of Medicine, Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy (e-mail: nicola.fazio@ieo.it).

The first 10% of the full text of this article appears below.

We read with great interest the recent article by Cascinu et al. (1). The authors compared an 8-week intensive platinum, epirubicin, leucovorin, fluorouracil regimen (PELFw) with a much less intensive "control" 5-fluorouracil/leucovorin regimen in patients with radically resected locally advanced gastric cancer (1) and reported no difference in terms . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Article about this Correspondence

Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial
Stefano Cascinu, Roberto Labianca, Carlo Barone, Armando Santoro, Carlo Carnaghi, Alessandra Cassano, Giordano D. Beretta, Vincenzo Catalano, Oscar Bertetto, Sandro Barni, Luciano Frontini, Enrico Aitini, Silvia Rota, Valter Torri, and Irene Floriani
J Natl Cancer Inst 2007 99: 601-607. [Abstract] [Full Text] [PDF]

Related Article in JNCI

Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial
Stefano Cascinu, Roberto Labianca, Carlo Barone, Armando Santoro, Carlo Carnaghi, Alessandra Cassano, Giordano D. Beretta, Vincenzo Catalano, Oscar Bertetto, Sandro Barni, Luciano Frontini, Enrico Aitini, Silvia Rota, Valter Torri, and Irene Floriani
J Natl Cancer Inst 2007 99: 601-607. [Abstract] [Full Text] [PDF]

Response to this Correspondence

Response: Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial
Stefano Cascinu, Mario Scartozzi, Carlo Barone, Roberto Labianca, Armando Santoro, Carlo Carnaghi, Giordano D. Beretta, Vincenzo Catalano, Sandro Barni, and Luciano Frontini
J Natl Cancer Inst 2007 99: 1346-1347. [Extract] [Full Text] [PDF]